Mark Dudman is a seasoned executive with a history of successfully launching companies and highly innovative products. He has held senior leadership roles in the Healthcare, Telecom, Billing Systems, and Robotic industries.
Mark is an active Healthcare speaker and holds technical and business advisory board positions at MIT. Mark is a vocal advocate for women in technology and is the founding leader of the Women of Watson Health Technical Guild with over 1800 active members.
Mark is the Head of Global Product and AI Development for IBM’s Watson Health. He provides management leadership and technical direction across the Oncology, Genomics, Life Sciences, Imaging, Payer, Provider, and Government market segments. Mark leads the innovation, execution, and delivery of Watson Health products and is responsible for a team of over 2,000 Architects, Engineers, Researchers, Physicians, and Data Scientists. His teams are achieving over 200 AI and Healthcare related technology patents each year.
Prior to joining IBM, Mark was the President of Product Operations at NantHealth, where he led global product research and development. In June of 2016, Dr. Patrick Soon-Shiong, Mark, and the executive team took NantHealth public with a very successful IPO.
Mark earned his bachelor’s degree in Computer Science from Rochester Institute of Technology.